WO2023175420 - A STABLE INJECTABLE COMPOSITION OF TRIAMCINOLONE ACETONIDE

National phase entry:
Publication Number WO/2023/175420
Publication Date 21.09.2023
International Application No. PCT/IB2023/051789
International Filing Date 27.02.2023
Title **
[English] A STABLE INJECTABLE COMPOSITION OF TRIAMCINOLONE ACETONIDE
[French] COMPOSITION INJECTABLE STABLE D'ACÉTONIDE DE TRIAMCINOLONE
Applicants **
INDOCO REMEDIES LIMITED
Inventors
PANANDIKAR, Aditi
BAMBOLKAR, Sundeep
INAMDAR, Dr. Kavita
WAWDE, Gopal
GUNDECHA, Chetan
SAWANT, Swati
Priority Data
202221014752   17.03.2022   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1965
EPO Filing, Examination, Granting11646
Japan Filing, Examination, Granting1985
South Korea Filing, Examination, Granting1715
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,051

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to a stable injectable composition of Triamcinolone acetonide and a method of preparing same, which is stable at controlled room temperature between 200C– 250C and packaged in glass material. Specifically, the triamcinolone acetonide injection of the present invention shows improved viscosity within range of 10-30 cps and osmolality within range of 270 to 370 mOsm/kg.[French] La présente invention concerne une composition injectable stable d'acétonide de triamcinolone et son procédé de préparation, qui est stable à température ambiante contrôlée entre 200C – 250C et conditionnée dans un matériau de verre. Spécifiquement, l'injection d'acétonide de triamcinolone de la présente invention présente une viscosité améliorée dans la plage de 10 à 30 cps et une osmolalité dans la plage de 270 à 370 mOsm/kg.

Rejoining the server...